172 related articles for article (PubMed ID: 19685155)
1. Glyceryl triacetate for Canavan disease: a low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model.
Madhavarao CN; Arun P; Anikster Y; Mog SR; Staretz-Chacham O; Moffett JR; Grunberg NE; Gahl WA; Namboodiri AMA
J Inherit Metab Dis; 2009 Oct; 32(5):640. PubMed ID: 19685155
[TBL] [Abstract][Full Text] [Related]
2. A safety trial of high dose glyceryl triacetate for Canavan disease.
Segel R; Anikster Y; Zevin S; Steinberg A; Gahl WA; Fisher D; Staretz-Chacham O; Zimran A; Altarescu G
Mol Genet Metab; 2011 Jul; 103(3):203-6. PubMed ID: 21474353
[TBL] [Abstract][Full Text] [Related]
3. Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease.
Arun P; Madhavarao CN; Moffett JR; Hamilton K; Grunberg NE; Ariyannur PS; Gahl WA; Anikster Y; Mog S; Hallows WC; Denu JM; Namboodiri AM
J Inherit Metab Dis; 2010 Jun; 33(3):195-210. PubMed ID: 20464498
[TBL] [Abstract][Full Text] [Related]
4. Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brain.
Mathew R; Arun P; Madhavarao CN; Moffett JR; Namboodiri MA
J Pharmacol Exp Ther; 2005 Oct; 315(1):297-303. PubMed ID: 16002461
[TBL] [Abstract][Full Text] [Related]
5. Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation.
Reisenauer CJ; Bhatt DP; Mitteness DJ; Slanczka ER; Gienger HM; Watt JA; Rosenberger TA
J Neurochem; 2011 Apr; 117(2):264-74. PubMed ID: 21272004
[TBL] [Abstract][Full Text] [Related]
6. Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease.
McPhee SW; Francis J; Janson CG; Serikawa T; Hyland K; Ong EO; Raghavan SS; Freese A; Leone P
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):112-21. PubMed ID: 15857674
[TBL] [Abstract][Full Text] [Related]
7. Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat.
Wang J; Leone P; Wu G; Francis JS; Li H; Jain MR; Serikawa T; Ledeen RW
Neurochem Res; 2009 Jan; 34(1):138-48. PubMed ID: 18478328
[TBL] [Abstract][Full Text] [Related]
8. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest.
Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM
J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156
[TBL] [Abstract][Full Text] [Related]
9. Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease.
Kirmani BF; Jacobowitz DM; Kallarakal AT; Namboodiri MA
Brain Res Mol Brain Res; 2002 Nov; 107(2):176-82. PubMed ID: 12487123
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time.
Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M
J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242
[TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M
Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375
[TBL] [Abstract][Full Text] [Related]
13. NTP toxicity report of reproductive dose range-finding study of Genistein (CAS No. 446-72-0) administered in feed to Sprague-Dawley rats.
Delclos KB; Newbold R
Toxic Rep Ser; 2007 Nov; (79):1-C2. PubMed ID: 18685712
[TBL] [Abstract][Full Text] [Related]
14. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
Willhite CC; Ball GL; McLellan CJ
Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
[TBL] [Abstract][Full Text] [Related]
15. Subchronic toxicity and concomitant toxicokinetics of long-term oral administration of total alkaloid extracts from seeds of Peganum harmala Linn: A 28-day study in rats.
Wang Y; Wang H; Zhang L; Zhang Y; Sheng Y; Deng G; Li S; Cao N; Guan H; Cheng X; Wang C
J Ethnopharmacol; 2019 Jun; 238():111866. PubMed ID: 30970283
[TBL] [Abstract][Full Text] [Related]
16. Canavan disease and the role of N-acetylaspartate in myelin synthesis.
Namboodiri AM; Peethambaran A; Mathew R; Sambhu PA; Hershfield J; Moffett JR; Madhavarao CN
Mol Cell Endocrinol; 2006 Jun; 252(1-2):216-23. PubMed ID: 16647192
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
19. Oral acetate supplementation attenuates N-methyl D-aspartate receptor hypofunction-induced behavioral phenotypes accompanied by restoration of acetyl-histone homeostasis.
Singh S; Choudhury A; Gusain P; Parvez S; Palit G; Shukla S; Ganguly S
Psychopharmacology (Berl); 2016 Apr; 233(7):1257-68. PubMed ID: 26832338
[TBL] [Abstract][Full Text] [Related]
20. Enhanced brain distribution of modified aspartoacylase.
Poddar NK; Zano S; Natarajan R; Yamamoto B; Viola RE
Mol Genet Metab; 2014 Nov; 113(3):219-24. PubMed ID: 25066302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
